In addition, IL-22 was shown to inhibit several hepatic lipogenic genes (Figure 2) (e.g., fatty acid synthase (FAS)), thereby reducing liver steatosis as well (234–236). This evidence concerns the gene IL22 and Hepatic steatosis.